# A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

> **NCT06664619** · PHASE3 · RECRUITING · sponsor: **Teva Branded Pharmaceutical Products R&D LLC** · enrollment: 724 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fp/ABS
- **DRUG:** FP
- **DRUG:** ABS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06664619
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-12
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 724 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06664619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06664619, "A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma". Retrieved via MORVS 2026-11-01 from https://api.morvs.ai/clinical/NCT06664619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*